A Self-management Approach for Dietary Sodium Restriction in Patients With CKD: A Randomized Controlled Trial

被引:53
作者
Humalda, Jelmer K. [1 ]
Klaassen, Gerald [1 ]
de Vries, Hanne [2 ]
Meuleman, Yvette [3 ,4 ]
Verschuur, Lara C. [1 ]
Straathof, Elisabeth J. M. [1 ]
Laverman, Gozewijn D. [2 ]
Bos, Willem Jan W. [5 ,6 ]
van der Boog, Paul J. M. [6 ]
Vermeulen, Karin M. [7 ]
Henkemans, Olivier A. Blanson [8 ]
Otten, Wilma [8 ]
de Borst, Martin H. [1 ]
van Dijk, Sandra [3 ]
Navis, Gerjan J. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands
[2] ZGT Hosp, Dept Nephrol, Almelo Hengelo, Netherlands
[3] Leiden Univ, Fac Social & Behav Sci, Dept Hlth Med & Neuropsychol, Leiden, Netherlands
[4] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands
[5] St Antonius Hosp, Dept Internal Med, Leiden, Netherlands
[6] Leiden Univ, Dept Internal Med, Med Ctr, Leiden, Netherlands
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
[8] Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands
关键词
CHRONIC KIDNEY-DISEASE; MULTIFACTORIAL INTERVENTION; NURSE-PRACTITIONERS; RAAS-BLOCKADE; HEALTH; HYDROCHLOROTHIAZIDE; REDUCTION; EXCRETION; BARRIERS; EFFICACY;
D O I
10.1053/j.ajkd.2019.10.012
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rationale & Objective: Patients with chronic kidney disease (CKD) are particularly sensitive to dietary sodium. We evaluated a self-management approach for dietary sodium restriction in patients with CKD. Study Design: Randomized controlled trial. Setting & Participants: Nephrology outpatient clinics in 4 Dutch hospitals. 99 adults with CKD stages 1 to 4 or a functioning (estimated glomerular filtration rate >= 25 mL/min/1.73 m(2)) kidney transplant, hypertension, and sodium intake >130 mmol/d. Intervention: Routine care was compared with routine care plus a web-based self-management intervention including individual e-coaching and group meetings implemented over a 3-month intervention period, followed by e-coaching over a 6-month maintenance period. Outcomes: Primary outcomes were sodium excretion after the 3-month intervention and after the 6-month maintenance period. Secondary outcomes were blood pressure, proteinuria, costs, quality of life, self-management skills, and barriers and facilitators for implementation. Results: Baseline estimated glomerular filtration rate was 55.0 +/- 22.0 mL/min/1.73 m(2). During the intervention period, sodium excretion decreased in the intervention group from 188 +/- 8 (SE) to 148 +/- 8 mmol/d (P < 0.001), but did not change significantly in the control group. At 3 months, mean sodium excretion was 24.8 (95% CI, 0.1-49.6) mmol/d lower in the intervention group (P = 0.049). At 3 months, systolic blood pressure (SBP) decreased in the intervention group from 140 +/- 3 to 132 +/- 3 mm Hg (P < 0.001), but was unchanged in the control group. Mean difference in SBP across groups was -4.7 (95% CI, -10.7 to 1.3) mm Hg (P = 0.1). During the maintenance phase, sodium excretion increased in the intervention group, but remained lower than at baseline at 160 +/- 8 mmol/d (P = 0.01), while it decreased in the control group from 174 +/- 9 at the end of the intervention period to 154 +/- 9 mmol/d (P = 0.001). Consequently, no difference in sodium excretion between groups was observed after the maintenance phase. There was no difference in SBP between groups after the maintenance phase. Limitations: Limited power, postrandomization loss to follow-up, Hawthorne effect, lack of dietary data, short-term follow-up. Conclusions: A coaching intervention reduced sodium intake at 3 months. Efficacy during the maintenance phase was diminished, possibly due to inadvertent adoption of the intervention by the control group.
引用
收藏
页码:847 / 856
页数:10
相关论文
共 31 条
[1]  
[Anonymous], 2004, AM J KIDNEY DIS
[2]  
[Anonymous], 2014, Measurement instrument for determinants of innovations (MIDI).
[3]  
[Anonymous], HANDLEIDING KOSTENON
[4]  
[Anonymous], 2012, KIDNEY INT SUPPL
[5]   Association of a Reduction in Central Obesity and Phosphorus Intake With Changes in Urinary Albumin Excretion: The PREMIER Study [J].
Chang, Alex ;
Batch, Bryan C. ;
McGuire, Heather L. ;
Vollmer, William M. ;
Svetkey, Laura P. ;
Tyson, Crystal C. ;
Sanguankeo, Anawin ;
Anderson, Cheryl ;
Houston, Jessica ;
Appel, Lawrence J. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (05) :900-907
[6]   Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) [J].
Cook, Nancy R. ;
Cutler, Jeffrey A. ;
Obarzanek, Eva ;
Buring, Julie E. ;
Rexrode, Kathryn M. ;
Kumanyika, Shiriki K. ;
Appel, Lawrence J. ;
Whelton, Paul K. .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7599) :885-888B
[7]   Sodium intake, RAAS-blockade and progressive renal disease [J].
de Borst, Martin H. ;
Navis, Gerjan .
PHARMACOLOGICAL RESEARCH, 2016, 107 :344-351
[8]   Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease [J].
Humalda, Jelmer K. ;
Navis, Gerjan .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (06) :533-540
[9]   Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial [J].
Kwakernaak, Arjan J. ;
Krikken, Jan A. ;
Binnenmars, S. Heleen ;
Visser, Folkert W. ;
Hemmelder, Marc H. ;
Woittiez, Arend-Jan ;
Groen, Henk ;
Laverman, Gozewijn D. ;
Navis, Gerjan .
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (05) :385-395
[10]   Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers [J].
Lambers Heerspink, Hiddo J. ;
Holtkamp, Frank A. ;
Parving, Hans-Henrik ;
Navis, Gerjan J. ;
Lewis, Julia B. ;
Ritz, Eberhard ;
de Graeff, Pieter A. ;
de Zeeuw, Dick .
KIDNEY INTERNATIONAL, 2012, 82 (03) :330-337